Mirabegron: A Beta-3 Agonist for Overactive Bladder

OBJECTIVE: To review the literature regarding the efficacy and safety of mirabegron for the treatment of overactive bladder (OAB). DATA SOURCES: A literature search was performed using MEDLINE (PubMed) prior to 12/31/2013 using the terms “mirabegron” and “randomized-controlled trial.” STUDY SELECTIO...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Consult Pharm
Asıl Yazarlar: Bragg, Rebecca, Hebel, Danielle, Vouri, Scott Martin, Pitlick, Jamie M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4605389/
https://ncbi.nlm.nih.gov/pubmed/25521658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4140/TCP.n.2014.823
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller